Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10153
|
1571
|
0.080 |
None |
0.875 |
8 |
|
2013 |
2020 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6481
|
2154
|
0.050 |
None |
1.000 |
5 |
|
2010 |
2018 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6500
|
2145
|
0.050 |
None |
1.000 |
5 |
|
2010 |
2018 |
Progressive Neoplastic Disease
|
phenotype |
|
Neoplastic Process
|
384
|
40
|
0.040 |
None |
1.000 |
4 |
|
2015 |
2019 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6345
|
327
|
0.040 |
None |
1.000 |
4 |
|
2014 |
2019 |
Progressive cGVHD
|
disease |
|
Disease or Syndrome
|
384
|
40
|
0.040 |
None |
1.000 |
4 |
|
2015 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2016 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2140
|
78
|
0.020 |
None |
1.000 |
2 |
|
2010 |
2014 |
Adenocarcinoma of lung (disorder)
|
disease |
Neoplasms
|
Neoplastic Process
|
2246
|
183
|
0.020 |
None |
1.000 |
2 |
|
2013 |
2014 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8577
|
1441
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2016 |
Carcinoma, Ovarian Epithelial
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2827
|
321
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Non-Small Cell Lung Carcinoma
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
3882
|
601
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |
Epithelial ovarian cancer
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
1214
|
109
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6241
|
355
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Intrahepatic Cholangiocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
462
|
19
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Thyroid carcinoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
1152
|
116
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Acute alcoholic intoxication
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
6
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Neuropathy
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
477
|
75
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Malignant neoplasm of ovary
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2520
|
246
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Triple-Negative Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1598
|
96
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Childhood Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
1740
|
140
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
360
|
31
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Triple Negative Breast Neoplasms
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1673
|
96
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
cervical cancer
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1809
|
257
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |